Page last updated: 2024-11-05
1-bromo-2,4-dinitrobenzene
Description
1-bromo-2,4-dinitrobenzene is a yellow crystalline solid that is used as an intermediate in the synthesis of other organic compounds. It is also a potential environmental contaminant and has been shown to be toxic to aquatic organisms. The compound is known to be a skin irritant and has been linked to skin sensitization. Research on 1-bromo-2,4-dinitrobenzene focuses on its synthesis, reactivity, and potential environmental impacts. Studies investigate its biological effects, its interactions with various substrates, and its potential for degradation and detoxification.'
2,4-dinitrobromobenzene : An organobromine compound that is bromobenzene substituted at C-2 and -4 with nitro groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 11441 |
CHEBI ID | 58999 |
SCHEMBL ID | 399325 |
MeSH ID | M0058198 |
Synonyms (37)
Synonym |
2-bromo-1,5-dinitrobenzene |
dnbb |
CHEBI:58999 |
4ms3ftw380 , |
unii-4ms3ftw380 |
4-bromo-1,3-dinitrobenzene |
2,4-dinitrobromobenzene |
nsc-3808 |
nsc3808 |
584-48-5 |
1-bromo-2,4-dinitrobenzene |
benzene, 1-bromo-2,4-dinitro- |
7238-15-5 |
2,4-dinitrophenyl bromide |
ai3-01803 |
ccris 1801 |
o,p-dinitrophenyl bromide |
nsc 3808 |
einecs 209-539-8 |
1-bromo-2,4-dinitrobenzene, 97% |
AC-10400 |
D2701 |
AKOS005258872 |
FT-0632441 |
bromo-2,4-dinitrobenzene |
2,4-dinitro-bromobenzene |
bromo-2,4-dinitrobenzene, 1- |
DTXSID3060403 |
SCHEMBL399325 |
2, 4-dinitrobromobenzene |
W-203191 |
1-bromo-2,4-dinitro-benzene |
mfcd00041873 |
AS-58751 |
Q27126388 |
1-bromo-2.4-dinitrobenzene |
BR1306 |
Research Excerpts
Toxicity
Dosage Studied
Excerpt | Relevance | Reference |
" The mercapturic acid conjugate in rats was also studied by collection of urine of rats dosed with radioactive DNBB by intraperitoneal injection." | ( Glutathione and mercapturic acid conjugations in the metabolism of 2,4-dinitrobromobenzene. Chen, KC; Dorough, HW, 1980) | 0.26 |
" By incorporating TDT values, shapes of the dose-response curves, chemical reactivity data with thiol, reactive mechanisms for the soft electrophiles, and quantitative structure activity relationship information on whether the toxicity of the individual soft electrophiles did or did not exceeded that predicted for baseline narcosis, the results suggested that the alpha-halogens elicited two toxic effects at the concentrations tested (reactivity and narcotizing effects), whereas toxicity induced by the halogenated dinitrobenzenes was essentially limited to reactive effects." | ( Time dependence in mixture toxicity with soft electrophiles: 1. Combined effects of selected SN2- and SNAr-reactive agents with a nonpolar narcotic. Dawson, DA; Gagan, EM; Hull, MW; Pöch, G; Schultz, TW, 2007) | 0.34 |
Drug Classes (2)
Class | Description |
organobromine compound | A compound containing at least one carbon-bromine bond. |
C-nitro compound | A nitro compound having the nitro group (-NO2) attached to a carbon atom. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.27
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 32.27 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.42 (4.65) | Search Engine Demand Index | 35.70 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |